Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-22-003436
Accepted
2022-12-05 00:15:19
Documents
1
Effectiveness Date
2022-12-02
Registration Form
S-4

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 599
  Complete submission text file 9999999995-22-003436.txt   1807
Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Gemini Therapeutics, Inc. /DE (Filer) CIK: 0001816736 (see all company filings)

EIN.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-267276 | Film No.: 221443640
SIC: 2834 Pharmaceutical Preparations